Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2005
06/09/2005CA2814523A1 Colonic purgative composition with soluble binding agent
06/09/2005CA2547999A1 Hemostatic pressure plug
06/09/2005CA2547446A1 Solid forms of anti-egfr-antibodies
06/09/2005CA2547427A1 Composition having liver function protective effect
06/09/2005CA2547398A1 Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
06/09/2005CA2547382A1 Method and system for rapid transdermal administration
06/09/2005CA2546677A1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof
06/09/2005CA2546675A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications
06/09/2005CA2546637A1 Colonic purgative composition with soluble binding agent
06/09/2005CA2546618A1 Composition and method for enhancing bioavailability
06/09/2005CA2546616A1 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
06/09/2005CA2546583A1 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
06/09/2005CA2546405A1 Peptidically buffered formulations for electrotransport applications and methods of making
06/09/2005CA2546399A1 Methods for preparing polymeric buffer formulations for electrotransport applications
06/09/2005CA2546280A1 Composition and apparatus for transdermal delivery
06/09/2005CA2546248A1 Phosphodiesterase v inhibitor formulations
06/09/2005CA2546244A1 Compositions comprising organic compounds
06/09/2005CA2545650A1 Injectable sustained release delivery devices
06/09/2005CA2545575A1 Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof
06/09/2005CA2545473A1 Macromolecular drug complexes having improved stability and therapeutic use of the same
06/09/2005CA2544404A1 Novel nimesulide compositions
06/09/2005CA2540621A1 Enhanced drug delivery
06/09/2005CA2536242A1 Implantable sensors and implantable pumps and anti-scarring agents
06/09/2005CA2536192A1 Soft tissue implants and anti-scarring agents
06/09/2005CA2536188A1 Electrical devices and anti-scarring agents
06/08/2005EP1538197A1 Decolorized yeast cell wall fraction
06/08/2005EP1538162A2 Compositions for altering mucus secretion
06/08/2005EP1538158A1 Proline ester and preparation containing the same for percutaneous administration
06/08/2005EP1537880A1 Sustained release preparation
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537868A1 Antifungal medicinal compositions
06/08/2005EP1537860A1 Vaccine composition, method of preparing the composition and method of vaccinating vertebrates
06/08/2005EP1537859A2 Azithromycin dosage forms with reduced side effects
06/08/2005EP1537858A1 Drug delivery vehicles and uses thereof
06/08/2005EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof
06/08/2005EP1537854A1 High lipid content sprayable emulsions
06/08/2005EP1537846A1 Process for the production of microspheres and unit therefor
06/08/2005EP1537208A1 Non-sequence complementary antiviral oligonucleotides
06/08/2005EP1537174A1 Cyclodextrin particle
06/08/2005EP1537163A2 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
06/08/2005EP1536934A1 Method and apparatus for making miniature tablets
06/08/2005EP1536849A1 Microarray drug delivery coatings
06/08/2005EP1536843A2 Radiolabeled compounds and liposomes and their methods of making and using the same
06/08/2005EP1536840A2 Formulation for inwardly transferring nucleic acids into eucaryotic cells
06/08/2005EP1536839A2 Method for treating diseases with omega interferon
06/08/2005EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
06/08/2005EP1536836A2 Topical emulsion- gel composition comprising diclofenac sodium
06/08/2005EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
06/08/2005EP1536822A1 Stable pharmaceutical composition comprising erythropoietin
06/08/2005EP1536816A2 Amelioration of effects of cigarette smoke
06/08/2005EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents
06/08/2005EP1536804A2 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536793A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
06/08/2005EP1536792A1 Pramipexole once-daily dosage form
06/08/2005EP1536791A1 Sustained-release tablet comprising reboxetine
06/08/2005EP1536788A1 Pharmaceutical solid dosage forms exhibiting reproductible drug release profile
06/08/2005EP1536783A2 Solid formulations comprising an indolinone compound
06/08/2005EP1536780A1 Oral liquid tolterodine composition
06/08/2005EP1536775A1 Compositions comprising hmg-coa reductase inhibitor
06/08/2005EP1536774A1 Taste masked dosage forms and processes for their preparation
06/08/2005EP1536773A2 Method of manufacturing albumin microspheres comprising antisense oligonucleotides (oligomers) to nf-kb
06/08/2005EP1536772A1 A pharmaceutical composition of small-sized liposomes and method of preparation
06/08/2005EP1536771A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
06/08/2005EP1536770A1 Thermolabile liposome with a controlled release temperature
06/08/2005EP1536769A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
06/08/2005EP1536768A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
06/08/2005EP1536767A1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
06/08/2005EP1511580A4 Lipobeads and their production
06/08/2005EP1441769B1 Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections
06/08/2005EP1390866A4 Container and method for dispensing transdermal dosage forms
06/08/2005EP1353654B1 Devices and methods for heat-pulse assisted thermal applications of active substances
06/08/2005EP1339418A4 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
06/08/2005EP1265595B1 Stabilized ascorbic acid solutions
06/08/2005EP1251858B1 Podophyllotoxin compositions
06/08/2005EP1244472B1 Particulate vitamin composition
06/08/2005EP1239844B1 Process for producing nanometer particles by fluid bed spray-drying
06/08/2005EP1204699B1 Pullulan film compositions
06/08/2005EP1165031B1 Resorcinol composition
06/08/2005EP1162956B1 Compositions and methods for improving integrity of compromised body passageways and cavities
06/08/2005EP1161940B1 Tablets and process for producing tablets
06/08/2005EP1147148B1 Dextran-maleic acid monoesters and hydrogels based thereon
06/08/2005EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains
06/08/2005EP1069919B1 Stimulus sensitive gel comprising a radioisotope and methods of making such gel
06/08/2005EP1017391B1 Sustained release tablet formulation to treat parkinson disease
06/08/2005EP1007013B1 Parenteral pimaricin as treatment of systemic infections
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005EP0914818B1 Intraorally rapidly disintegrable tablet
06/08/2005EP0862391B1 Retrievable bioartificial implants
06/08/2005EP0835103B1 Nanoparticles for oral administration of pharmaceutical agents of low solubility
06/08/2005CN2703520Y Medicinal plaster for pneumonia
06/08/2005CN1625420A Medical treatment system and production method therefor
06/08/2005CN1625414A Pharmaceutical composition
06/08/2005CN1625413A Multifunction biocompatible hydrogel and preparation method thereof
06/08/2005CN1625399A Pharmaceutical composition for regeneration of cirrhotic liver
06/08/2005CN1625397A Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
06/08/2005CN1625392A Composition for inhalation
06/08/2005CN1625391A Cyclosporin-containing sustained release pharmaceutical composition
06/08/2005CN1625390A Multi-stage oral drug controlled-release system
06/08/2005CN1625389A Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
1 ... 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 ... 2991